eye disease
Conditions
Interventions
Group A:Plain frame glasses
Group B:General frame +0.01% atropine 1 time before going to bed
Group C:Normal frame +0.01% atropine before going to sleep 2 times
Group D:DIMS frame lens +0.01% atropine one time before going to bed
Sponsors
Shenyang Xingqi Pharmaceutical Co., Ltd.
Eligibility
Sex/Gender
All
Age
7 Years to 12 Years
Inclusion criteria
Inclusion criteria: 1) Binocular BCVA >= 0.8, binocular near vision and normal regulation ability; 2) Dioptric examination: ball mirror degree -1.00 ~ -6.00d, regular astigmatism 0.2); 4) Pupil size 2. 5 ~ 4mm;
Exclusion criteria
Exclusion criteria: 1) Patients with ocular or systemic diseases are not suitable for atropine eye drops; 2) Patients with systemic diseases should take long-term medication (such as hormones, atropine, non-steroidal anti-inflammatory drugs, etc.) or use the treatment plan that affects the change of myopia degree during the observation period; 3) Poor near vision and abnormal regulation ability; 4) Nearly 3MO patients who have worn contact lens or applied other relevant treatment measures; 5) Poor compliance, unable to cooperate with the examination, treatment on time or come to the hospital for review at regular intervals; 6) Patients with allergies to related drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| refractive diopter;length of optic axis; | — |
Secondary
| Measure | Time frame |
|---|---|
| pupil diameter;Regulating aggregate capacity;IOP (intraocular pressure); | — |
Countries
China
Contacts
Public ContactGao Xu
Bishan People's Hospital of Chongqing
Outcome results
None listed